US vaccine maker Moderna will make its first investment in China worth up to USD1 billion, according to sources. Stéphane Bancel, chief executive officer of Moderna, has arrived in Shanghai and will attend the investment’s signing ceremony today,
-
-
Recent Updates
- China’s stocks fall as AI hardware selloff, weak data weigh
- Chinese cartoon exhibition features 300 works in Shanghai
- Shanghai draws intl patients with cutting-edge healthcare innovations
- China Access Health Expands Its Presence with Two New Offices in Shanghai and Beijing
- Chinese-Made EVs Set for Wider Canada Rollout in 2027
- China Canal Power Struggle Engulfs Panama Port Dealmaker Facing Extradition
- Spider-bots reveal new mural for Shanghai Disneyland’s Spider-Man land
- China and US Open Trade Council Talks on Tariffs and Farm Commerce
- Chinese Electric Vehicles Are Poised for More Canadian Roads in 2027
- Nvidia Chip Back Door to China Faces US Crackdown
Blogroll